AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention

Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix???]

(2008) Susan J Keam et al.   DRUGS

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

(2008) David Jenkins   GYNECOLOGIC ONCOLOGY

Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature

(2008) Tino F. Schwarz et al.   GYNECOLOGIC ONCOLOGY

Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of age

(2008) Diane M. Harper   GYNECOLOGIC ONCOLOGY

Human Papillomavirus Vaccination — Reasons for Caution

(2008) Charlotte J. Haug   NEW ENGLAND JOURNAL OF MEDICINE

Health and Economic Implications of HPV Vaccination in the United States

(2008) Jane J. Kim et al.   NEW ENGLAND JOURNAL OF MEDICINE

EUROGIN 2007 roadmap—Conclusion

(2008) Cosette M. Wheeler et al.   VACCINE

Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement

(2008) Jon Kim Andrus et al.   VACCINE